17 July 2020 - Dossiers submitted for early benefit assessments in Germany also provide information on the precise determination of the ...
7 July 2020 - BMJ publication headed by IQWiG: relevant controlled studies and individual patient data are necessary for informative ...
1 July 2020 - Informative comparative data are missing / resistance situation not sufficiently considered in approval studies. ...
15 June 2020 - Payers are increasingly calling for the value of new drugs to be measured explicitly. ...
15 June 2020 - Fewer vertebral fractures and fewer other typical fractures in postmenopausal women with severe osteoporosis at high ...
3 June 2020 - The German system for determining drug prices features collective negotiations on the part of competing health plans. ...
2 June 2020 - Re-valuations after the expiry of the time limit new data cuts confirm advantages and disadvantages ...
14 May 2020 - Addendum with a new summary; subsequent information enables the benefits to be assessed. ...
22 April 2020 - The European Network for Health Technology Assessment (EUnetHTA) organises an annual Forum with stakeholders to receive feedback ...
11 March 2020 - The understanding of the benefit risk profile, and relative effectiveness of a new medicinal product, are initially ...
10 March 2020 - For at least two decades, health technology assessment has been considered worldwide the most comprehensive and suitable ...
24 January 2020 - Rapid report shows how routine practice data should be collected and processed. ...
15 January 2020 - Weak evidence does not allow a specific statement to be made about the extent of the added ...
15 January 2020 - First assessment of a histology-independent drug/studies without control arms. ...
14 January 2020 - HTA recommendations vary widely throughout Europe, even for the same medicine. ...